Despite many successes in 2023, the biotechnology industry saw a year-on-year decline in market capitalisation for the first time since 2012, according to GEN’s A-list. The largest biotech companies closed the year with a total market cap of $1.711 trillion, down 2.2% from the previous year. The decline reflects falling vaccine sales, increasing financial insecurity, and upcoming patent expiration for several major drugs.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
